Regulatory Consulting Firm: DDReg Pharma

The Brazilian pharmaceutical market is one of the most dynamic and stringently regulated in Latin America.     For global life sciences companies, entering this territory offers immense opportunity, but it also requires a deep understanding of the Agência Nacional de Vigilância Sanitária (ANVISA) .     At DDReg Pharma , we bridge the gap between global innovation and local compliance, providing specialized Regulatory Affairs and Pharmacovigilance (PV) services tailored to the Brazilian market. The ANVISA Challenge: Beyond Just Paperwork ANVISA is known for its rigorous standards, often harmonizing with international bodies like ICH and WHO, yet maintaining unique local requirements. Successfully launching a product in Brazil isn't just about submitting a dossier; it’s about strategic alignment. From ensuring Good Manufacturing Practice (GMP) certification to managing the complexity of eCTD/CTD submissions, the hurdles are significant. This is where DDReg Pharma ...